(Alliance News) - The FTSE 100 fell on Thursday despite well-received earnings, but mid-caps extended their recent gains, lifted by advances by WPP and easyJet. Read More
(Alliance News) - The FTSE 100 underperformed European peers on Monday as heavy falls in AstraZeneca outweighed more optimistic noises in the Middle East. Read More
(Alliance News) - Stock prices in London were mixed at midday on Monday, with the FTSE 100 underperforming its European peers as weakness in AstraZeneca and IG Group offset gains among housebuilders. Read More
(Alliance News) - Stock prices in London opened mixed on Monday, with the FTSE 100 lagging its European peers as a sharp fall in AstraZeneca shares offset gains elsewhere, while investors also weighed renewed US-Iran diplomacy. Read More
(Alliance News) - AstraZeneca PLC and Bristol-Myers Squibb Co are considering merging in a deal worth USD400 billion, the Financial Times reported on Sunday. Read More
(Alliance News) - Stocks in London are set to open higher on Monday as hopes for renewed US-Iran diplomacy offset caution following a joint US-Japan intervention to strengthen the yen. Read More
(Alliance News) - AstraZeneca PLC on Friday said the European Commission has approved Datroway for the first-line treatment of some patients with an aggressive form of breast cancer. Read More
(Alliance News) - The FTSE 100 closed higher in London on Monday as investors welcomed a temporary pause in hostilities between the US and Iran, which helped drive the oil price sharply lower. Read More
(Alliance News) - European shares moved higher at the start of the week, as a pause in US and Iran hostilities lifted hopes of a prolonged peace agreement, and sent oil into reverse. Read More
(Alliance News) - AstraZeneca PLC on Monday reported stronger-than-expected earnings in its second quarter, with sales broadly as forecast, together with mixed news for its drugs pipeline. Read More
(Alliance News) - AstraZeneca affirmed annual guidance, while Vodafone lifted its outlook after the Safaricom deal. Elsewhere, DCC Energy has agreed to a takeover, Serica Energy will buy Pharos Energy but IP Group's suitor will not make an offer for the firm. Read More
(Alliance News) - AstraZeneca PLC on Thursday said a combination with its Etcamah drug has been approved for treatment of breast cancer in the EU. Read More